Drotrecogin alfa (activated) in severe sepsis

Comment

Paul E Marik. Lancet Infect Dis. 2013 Feb.

. 2013 Feb;13(2):107.

doi: 10.1016/S1473-3099(12)70311-0.

No abstract available

Comment in

Drotrecogin alfa (activated) in severe sepsis--authors' reply.
Kalil AC, LaRosa SP. Kalil AC, et al. Lancet Infect Dis. 2013 Feb;13(2):110-1. doi: 10.1016/S1473-3099(12)70350-X. Lancet Infect Dis. 2013. PMID: 23347628 No abstract available.

Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression.
Kalil AC, LaRosa SP. Kalil AC, et al. Lancet Infect Dis. 2012 Sep;12(9):678-86. doi: 10.1016/S1473-3099(12)70157-3. Epub 2012 Jul 17. Lancet Infect Dis. 2012. PMID: 22809883
The rise and fall of drotrecogin alfa (activated).
Vincent JL. Vincent JL. Lancet Infect Dis. 2012 Sep;12(9):649-51. doi: 10.1016/S1473-3099(12)70175-5. Epub 2012 Jul 17. Lancet Infect Dis. 2012. PMID: 22809884 No abstract available.